Journal History
| 2021 | The inaugural issue was released. Immuno was published as a quarterly journal. Immuno was indexed in DOAJ. |
| 2023 | Immuno published its 100th paper. Immuno was indexed in Emerging Sources Citation Index (ESCI)—Web of Science (Clarivate Analytics), starting with Volume 1 (Issue 1). Immuno was indexed in Scopus (Elsevier), starting with Volume 1 (Issue 1). |
| 2026 |
Immuno received its 2025 Impact Factor (2.7), ranked 151/466 (Q2) in "Medicine (miscellaneous)". Immuno received its 2025 CiteScore (4.1), ranked 52/144 (Q2) in "Biochemistry, Genetics and Molecular Biology (miscellaneous)". |
Editor-in-Chief
| 2021–present | Editor-in-Chief: Prof. Dr. Toshihiko Torigoe (Founding Editor) |
Section Editor-in-Chief
| 2021–2024 | Section Editor-in-Chief: Prof. Dr. Marcos López Hoyos for the section on Autoimmunity and Immunoregulation |

